The 21-gene recurrence score assay in node-negative early breast cancer: Prognostic, predictive or presumptuous?
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 2016
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Breast Neoplasms (MeSH)
- Gene Expression Profiling (MeSH)
- Humans (MeSH)
- Neoplasm Recurrence, Local (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Prognosis (MeSH)
- Receptors, Estrogen (MeSH)
published in
- European Journal of Cancer Journal